Lipopolysaccharides (LPSs) are of importance in bacterial physiology, and also in host-bacteria crosstalk [
1]. The pathogenicity of Gram-negative bacteria is influenced by the molecular variability (structures and lengths) of LPSs, e.g., serum sensitivity and biofilm forming ability of Gram-negative bacteria are correlated with the lengths of O sidechains. Previous studies have described that
R-type bacteria with truncated LPS molecules (so-called lipooligosaccharides—LOSs) are more sensitive to hydrophobic antibiotics [
2].
Recent studies suggested that
Shigella sonnei have become more dominant in developed countries [
3]. The history of
S. sonnei 4303 dates back more than 60 years, when the phenomenon of phase variation in
S. sonnei was examined [
4]. This non-pathogenic strain was formed by plasmid loss from a pathogenic
S. sonnei phase I. strain, due to the instable nature of the virulence plasmid [
5]. Later, intensive studies were carried out on the strain and its
R-type isogenic derivatives, and the chemical structures and structural variabilities of their lipopolysaccharides and lipooligosaccharides (LOSs) have been described. Several interesting
R mutants were characterized, including an absolute
R-type strain (
S. sonnei 4350) and a strain having truncated LPSs with a
d-glycero-
d-mannoheptose component incorporated in the structure (
S. sonnei 4351) [
6‐
12]. The lack of appropriate genome-scale information of the investigated strains, including structurally different LPSs, however, hinders our ability to answer fundamental biosynthetic questions. In order to gain more insight into the mechanism of the LPS/LOS biosynthesis
S. sonnei 4303 was subjected to whole genome sequencing.